MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast

Enrico Baruffini, Cristina Dallabona, Federica Invernizzi, John W. Yarham, Laura Melchionda, Emma L. Blakely, Eleonora Lamantea, Claudia Donnini, Saikat Santra, Suresh Vijayaraghavan, Helen P. Roper, Alberto Burlina, Robert Kopajtich, Anett Walther, Tim M. Strom, Tobias B. Haack, Holger Prokisch, Robert W. Taylor, Ileana Ferrero, Massimo Zeviani & 1 others Daniele Ghezzi

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We report three families presenting with hypertrophic cardiomyopathy, lactic acidosis, and multiple defects of mitochondrial respiratory chain (MRC) activities. By direct sequencing of the candidate gene MTO1, encoding the mitochondrial-tRNA modifier 1, or whole exome sequencing analysis, we identified novel missense mutations. All MTO1 mutations were predicted to be deleterious on MTO1 function. Their pathogenic role was experimentally validated in a recombinant yeast model, by assessing oxidative growth, respiratory activity, mitochondrial protein synthesis, and complex IV activity. In one case, we also demonstrated that expression of wt MTO1 could rescue the respiratory defect in mutant fibroblasts. The severity of the yeast respiratory phenotypes partly correlated with the different clinical presentations observed in MTO1 mutant patients, although the clinical outcome was highly variable in patients with the same mutation and seemed also to depend on timely start of pharmacological treatment, centered on the control of lactic acidosis by dichloroacetate. Our results indicate that MTO1 mutations are commonly associated with a presentation of hypertrophic cardiomyopathy, lactic acidosis, and MRC deficiency, and that ad hoc recombinant yeast models represent a useful system to test the pathogenic potential of uncommon variants, and provide insight into their effects on the expression of a biochemical phenotype.

Original languageEnglish
Pages (from-to)1501-1509
Number of pages9
JournalHuman Mutation
Volume34
Issue number11
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Lactic Acidosis
Hypertrophic Cardiomyopathy
Electron Transport
Yeasts
Mutation
Exome
Phenotype
Mitochondrial Diseases
Mitochondrial Proteins
Missense Mutation
Transfer RNA
Fibroblasts
Pharmacology
Growth
Genes
Therapeutics

Keywords

  • Hypertrophic cardiomyopathy
  • Lactic acidosis
  • Mitochondrial disorder
  • MTO1
  • Yeast

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Baruffini, E., Dallabona, C., Invernizzi, F., Yarham, J. W., Melchionda, L., Blakely, E. L., ... Ghezzi, D. (2013). MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. Human Mutation, 34(11), 1501-1509. https://doi.org/10.1002/humu.22393

MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. / Baruffini, Enrico; Dallabona, Cristina; Invernizzi, Federica; Yarham, John W.; Melchionda, Laura; Blakely, Emma L.; Lamantea, Eleonora; Donnini, Claudia; Santra, Saikat; Vijayaraghavan, Suresh; Roper, Helen P.; Burlina, Alberto; Kopajtich, Robert; Walther, Anett; Strom, Tim M.; Haack, Tobias B.; Prokisch, Holger; Taylor, Robert W.; Ferrero, Ileana; Zeviani, Massimo; Ghezzi, Daniele.

In: Human Mutation, Vol. 34, No. 11, 11.2013, p. 1501-1509.

Research output: Contribution to journalArticle

Baruffini, E, Dallabona, C, Invernizzi, F, Yarham, JW, Melchionda, L, Blakely, EL, Lamantea, E, Donnini, C, Santra, S, Vijayaraghavan, S, Roper, HP, Burlina, A, Kopajtich, R, Walther, A, Strom, TM, Haack, TB, Prokisch, H, Taylor, RW, Ferrero, I, Zeviani, M & Ghezzi, D 2013, 'MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast', Human Mutation, vol. 34, no. 11, pp. 1501-1509. https://doi.org/10.1002/humu.22393
Baruffini, Enrico ; Dallabona, Cristina ; Invernizzi, Federica ; Yarham, John W. ; Melchionda, Laura ; Blakely, Emma L. ; Lamantea, Eleonora ; Donnini, Claudia ; Santra, Saikat ; Vijayaraghavan, Suresh ; Roper, Helen P. ; Burlina, Alberto ; Kopajtich, Robert ; Walther, Anett ; Strom, Tim M. ; Haack, Tobias B. ; Prokisch, Holger ; Taylor, Robert W. ; Ferrero, Ileana ; Zeviani, Massimo ; Ghezzi, Daniele. / MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast. In: Human Mutation. 2013 ; Vol. 34, No. 11. pp. 1501-1509.
@article{97f82967ae3c4fe3a0828540ee2f350a,
title = "MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast",
abstract = "We report three families presenting with hypertrophic cardiomyopathy, lactic acidosis, and multiple defects of mitochondrial respiratory chain (MRC) activities. By direct sequencing of the candidate gene MTO1, encoding the mitochondrial-tRNA modifier 1, or whole exome sequencing analysis, we identified novel missense mutations. All MTO1 mutations were predicted to be deleterious on MTO1 function. Their pathogenic role was experimentally validated in a recombinant yeast model, by assessing oxidative growth, respiratory activity, mitochondrial protein synthesis, and complex IV activity. In one case, we also demonstrated that expression of wt MTO1 could rescue the respiratory defect in mutant fibroblasts. The severity of the yeast respiratory phenotypes partly correlated with the different clinical presentations observed in MTO1 mutant patients, although the clinical outcome was highly variable in patients with the same mutation and seemed also to depend on timely start of pharmacological treatment, centered on the control of lactic acidosis by dichloroacetate. Our results indicate that MTO1 mutations are commonly associated with a presentation of hypertrophic cardiomyopathy, lactic acidosis, and MRC deficiency, and that ad hoc recombinant yeast models represent a useful system to test the pathogenic potential of uncommon variants, and provide insight into their effects on the expression of a biochemical phenotype.",
keywords = "Hypertrophic cardiomyopathy, Lactic acidosis, Mitochondrial disorder, MTO1, Yeast",
author = "Enrico Baruffini and Cristina Dallabona and Federica Invernizzi and Yarham, {John W.} and Laura Melchionda and Blakely, {Emma L.} and Eleonora Lamantea and Claudia Donnini and Saikat Santra and Suresh Vijayaraghavan and Roper, {Helen P.} and Alberto Burlina and Robert Kopajtich and Anett Walther and Strom, {Tim M.} and Haack, {Tobias B.} and Holger Prokisch and Taylor, {Robert W.} and Ileana Ferrero and Massimo Zeviani and Daniele Ghezzi",
year = "2013",
month = "11",
doi = "10.1002/humu.22393",
language = "English",
volume = "34",
pages = "1501--1509",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast

AU - Baruffini, Enrico

AU - Dallabona, Cristina

AU - Invernizzi, Federica

AU - Yarham, John W.

AU - Melchionda, Laura

AU - Blakely, Emma L.

AU - Lamantea, Eleonora

AU - Donnini, Claudia

AU - Santra, Saikat

AU - Vijayaraghavan, Suresh

AU - Roper, Helen P.

AU - Burlina, Alberto

AU - Kopajtich, Robert

AU - Walther, Anett

AU - Strom, Tim M.

AU - Haack, Tobias B.

AU - Prokisch, Holger

AU - Taylor, Robert W.

AU - Ferrero, Ileana

AU - Zeviani, Massimo

AU - Ghezzi, Daniele

PY - 2013/11

Y1 - 2013/11

N2 - We report three families presenting with hypertrophic cardiomyopathy, lactic acidosis, and multiple defects of mitochondrial respiratory chain (MRC) activities. By direct sequencing of the candidate gene MTO1, encoding the mitochondrial-tRNA modifier 1, or whole exome sequencing analysis, we identified novel missense mutations. All MTO1 mutations were predicted to be deleterious on MTO1 function. Their pathogenic role was experimentally validated in a recombinant yeast model, by assessing oxidative growth, respiratory activity, mitochondrial protein synthesis, and complex IV activity. In one case, we also demonstrated that expression of wt MTO1 could rescue the respiratory defect in mutant fibroblasts. The severity of the yeast respiratory phenotypes partly correlated with the different clinical presentations observed in MTO1 mutant patients, although the clinical outcome was highly variable in patients with the same mutation and seemed also to depend on timely start of pharmacological treatment, centered on the control of lactic acidosis by dichloroacetate. Our results indicate that MTO1 mutations are commonly associated with a presentation of hypertrophic cardiomyopathy, lactic acidosis, and MRC deficiency, and that ad hoc recombinant yeast models represent a useful system to test the pathogenic potential of uncommon variants, and provide insight into their effects on the expression of a biochemical phenotype.

AB - We report three families presenting with hypertrophic cardiomyopathy, lactic acidosis, and multiple defects of mitochondrial respiratory chain (MRC) activities. By direct sequencing of the candidate gene MTO1, encoding the mitochondrial-tRNA modifier 1, or whole exome sequencing analysis, we identified novel missense mutations. All MTO1 mutations were predicted to be deleterious on MTO1 function. Their pathogenic role was experimentally validated in a recombinant yeast model, by assessing oxidative growth, respiratory activity, mitochondrial protein synthesis, and complex IV activity. In one case, we also demonstrated that expression of wt MTO1 could rescue the respiratory defect in mutant fibroblasts. The severity of the yeast respiratory phenotypes partly correlated with the different clinical presentations observed in MTO1 mutant patients, although the clinical outcome was highly variable in patients with the same mutation and seemed also to depend on timely start of pharmacological treatment, centered on the control of lactic acidosis by dichloroacetate. Our results indicate that MTO1 mutations are commonly associated with a presentation of hypertrophic cardiomyopathy, lactic acidosis, and MRC deficiency, and that ad hoc recombinant yeast models represent a useful system to test the pathogenic potential of uncommon variants, and provide insight into their effects on the expression of a biochemical phenotype.

KW - Hypertrophic cardiomyopathy

KW - Lactic acidosis

KW - Mitochondrial disorder

KW - MTO1

KW - Yeast

UR - http://www.scopus.com/inward/record.url?scp=84885434357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885434357&partnerID=8YFLogxK

U2 - 10.1002/humu.22393

DO - 10.1002/humu.22393

M3 - Article

VL - 34

SP - 1501

EP - 1509

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 11

ER -